Albert David (BOM:524075) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Albert David FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Albert David's Free Cash Flow for the three months ended in Dec. 2023 was ₹0 Mil. Albert David's Revenue for the three months ended in Dec. 2023 was ₹883 Mil. Therefore, Albert David's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Albert David's current FCF Yield % is 0.78%.

The historical rank and industry rank for Albert David's FCF Margin % or its related term are showing as below:

BOM:524075' s FCF Margin % Range Over the Past 10 Years
Min: -0.07 Med: 7.41 Max: 19.47
Current: 1.49

During the past 13 years, the highest FCF Margin % of Albert David was 19.47%. The lowest was -0.07%. And the median was 7.41%.

BOM:524075's FCF Margin % is ranked better than
54.63% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.2 vs BOM:524075: 1.49

Albert David FCF Margin % Historical Data

The historical data trend for Albert David's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert David FCF Margin % Chart

Albert David Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

9.56

4.66

14.20

9.39

1.55

Albert David Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Albert David's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Albert David's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Albert David's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Albert David's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Albert David's FCF Margin % falls into.

Albert David FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Albert David's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	52.781	/	3400.087
	=	1.55 %

Albert David's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	882.81
	=	0.00 %

Albert David FCF Margin % Related Terms

Thank you for viewing the detailed overview of Albert David's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Albert David (BOM:524075) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Albert David Ltd (BOM:524075) » Definitions » FCF Margin %

Traded in Other Exchanges

ALBERTDAVD:India

Address

8, Netaji Subhas Road, D-Block, 3rd Floor, Gillander House, Kolkata, WB, IND, 700001

Website

https://www.albertdavidindia.com

Albert David Ltd is engaged in the manufacturing and trading of pharmaceutical products. The company offers products such as pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Its formulation product covers parenteral, oral, and enteral, topical agents, and vision care solutions. The company exports its product to regions like Latin America, South East Asia, and a few African countries.

Albert David (BOM:524075) Headlines

No Headlines